DVA vs. FMS

In the year-to-date period, DVA achieves a 50.26% return, which is significantly higher than FMS's 9.29% return. Over the past 10 years, DVA has outperformed FMS with an annualized return of 7.78%, while FMS has yielded a comparatively lower -3.11% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for DaVita Inc. (DVA) and Fresenius Medical Care AG & Co. KGaA (FMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current DVA Sharpe Ratio is 2.28, which is higher than the FMS Sharpe Ratio of 0.58. The chart below compares the historical Sharpe Ratios of DVA and FMS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

DVA has not paid dividends to shareholders, while FMS's dividend yield for the trailing twelve months is around 2.87%.

The maximum DVA drawdown since its inception was -92.91%, which is greater than FMS's maximum drawdown of -77.28%. Use the drawdown chart below to compare losses from any high point for DVA and FMS. For additional features, visit the drawdowns tool.

DaVita Inc. (DVA) has a higher volatility of 14.21% compared to Fresenius Medical Care AG & Co. KGaA (FMS) at 10.34%. This indicates that DVA's price experiences larger fluctuations and is considered to be riskier than FMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between DaVita Inc. and Fresenius Medical Care AG & Co. KGaA. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.